What is BBC's market cap?

$43.82M, based on the Sep 28 close of $46.13.

Does Virtus Biotech Clinical Trials ETF pay a dividend?

Yes. The latest regular dividend was $0.6554 per share (ex-date Dec 22), an annualised yield of 1.42%.

NYSE Arca · BBC

Virtus Biotech Clinical Trials ETF (BBC)

$46.13+2.17%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$46.13▲ 70.47% in range

Sep 29, 2025Low $27.06 · High $56.02Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

Virtus Biotech Clinical Trials ETF closed at $46.13 on Sep 28, up 2.17%, 17.7% below its 52-week closing high. Volume of 23.0K shares was 1.24× its 20-day average (close to normal).

Split-adjusted performance: -16.6% over one month, +16.6% over six months, +79.8% over one year.

Short interest was 65.1K shares at the Sep 15 settlement, down 8.3% from the prior report (4.7 days to cover).

Market cap$43.8M950.0K shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yield1.42%$0.6554 last paid

52-week range25.65 – 56.02−17.7% from high

Volume23.0K1.24× 20-day avg

Volatility · 60d34.6%Annualised

Short % of float—4.7 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W −5.3%1M −16.6%3M −12.2%6M +16.6%YTD +19.6%1Y +79.8%3Y +131.6%5Y −1.3%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short65.1K−8.3% vs prior

Days to cover4.7Settled Sep 15

% of float—

Short vol. 10d23.6%of daily volume

News about Virtus Biotech Clinical Trials ETF

All news →

No recent articles focused on Virtus Biotech Clinical Trials ETF.

Quick answers

What is BBC's market cap?: $43.82M, based on the Sep 28 close of $46.13.
Does Virtus Biotech Clinical Trials ETF pay a dividend?: Yes. The latest regular dividend was $0.6554 per share (ex-date Dec 22), an annualised yield of 1.42%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology